Published • loading... • Updated
Microfluidic technique boosts CAR T cell transduction at low viral doses
Summary by BIOENGINEER.ORG
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Scienmag: Latest Science and Health NewsReposted by 
BIOENGINEER.ORG
BIOENGINEER.ORGMicrofluidic technique boosts CAR T cell transduction at low viral doses
CAR-T cell therapy has transformed the treatment of certain blood cancers, but the manufacturing process behind these engineered immune cells remains slow, expensive, and demanding. Now, a research team at The Second Qilu Hospital of Shandong University in China has developed a microfluidic approach that dramatically compresses the core manufacturing timeline for CD19-targeting CAR-T cells […]
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
